Mark R. Bamforth, Director at Avid Bioservices, Inc. (CDMO), bought 26,000 shares at $4.01 ($104K) on 2020-03-13, disclosed to the SEC on 2020-03-16.
Open-market purchase of $104k CDMO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CDMO | BUY | 2018-02-20 | $113K | — | Filing → |
| PPHM | BUY | 2017-10-27 | $444K | — | Filing → |
| GENZ | BUY | 2009-03-06 | $38K | — | Filing → |